Status:
COMPLETED
Fluency Stent-Graft Versus Luminex Stent for Angioplasty of Recurrent Stenosis of the Cephalic Arch in Autogenous Arteriovenous (AV) Access for Hemodialysis
Lead Sponsor:
Shaare Zedek Medical Center
Conditions:
Stenosis
Eligibility:
All Genders
15+ years
Phase:
PHASE4
Brief Summary
The type of hemodialysis access and preservation of this access greatly influences the quality of life and survival of patients undergoing hemodialysis. The Kidney Disease Outcomes Quality Initiative ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients included in this study would be presented for intervention after observation in the Vascular Access Unit for one of the following:
- the recurrent cephalic arch stenosis identified on periodic duplex scanning, performed by one of the surgeons from the Vascular Access Unit;
- reduction of flow rate of more than 20% from baseline access flow rate;
- dynamic venous pressures exceeded threshold levels three consecutive times; or
- clinical signs (arm swelling, pulsatile fistula, prolonged bleeding from puncture sites) suggesting fistula dysfunction in a patient with previously treated cephalic arch stenosis.
Exclusion
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
End Date :
August 1 2006
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00318435
Start Date
May 1 2006
End Date
August 1 2006
Last Update
August 19 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shaare Zedek Medical Center
Jerusalem, Israel